Cell & Gene therapy

Mastering the complex CAR T manufacturing process and the associated supply chain challenges in the cell and gene area are the major bottlenecks during the large-scale commercialization of highly promising CAR T cell products. 

Gene therapies have become a highly promising field of groundbreaking next generation treatment, but there are some challenges to face within the manufacturing process. Here are 5 factors that will be crucial for upscaling gene therapy manufacturing with single-use technology.

Cell and Gene therapies such as CAR T-cell therapy have proven their potential to become standard treatments to hard-to-treat diseases. Single Use Support has developed solutions for crucial challenges - read more!

CAR T-cell treatments are deservedly on the rise, as the effectiveness of CAR T-cell products for formerly hard to treat hematology malignancies has been established in clinical trials. This article will highlight one of the less discussed issues of immunotherapy in cancer treatment: it’s current price tag could hamper the broad accessibility to patients.

The geographical and socioeconomic distribution of CAR T-cell therapy is still leaving space for improvement. Read the following article to find out why and how Single Use Support will help!

Success rate of a CAR T-cell therapy | reliable and sterile logistics process | Single Use Support's scalable and agile systems based on single-use compounds will help - read more!

Single Use Support is solving problems related to supply chain management through the development of smart packaging and related smart technologies for CAR T-cell therapy. Read more!

Single Use Support develops scalable solutions and optimizes processes for protecting, fill & freeze, shockfreezing, packaging and handling of small volume cell and gene therapeutics. Learn more about logistics for CAR T-cell therapy!

A great example is the treatment of insidious cancers with CAR T-cells, that relies on modifying the patient’s own T-cells to instill them with a targeted way to fight cancer cells. Learn more why forming strong collaborations will solve many issues!

CAR-NK therapies are a new approach to combat cancer cells. 
This article sheds light on its advantages and logistical challenges  to avoid loss of these highly valuable drug substances and scalability.

In recent years, if not decades, gene therapies have proven to be key drivers of growth in the pharmaceutical industry. Learn more how SUSupport takes on the chances in loss of drug substances.

The term CGT stands for Cell and Gene Therapy and describes a range of new personalized therapies that are promising in the treatment of some diseases. For which diseases is the therapy suitable?